6% drop of H1 sales of Stada Arzneimittel in Czech Republic

2010-08-23

In the first six months of 2010 Aliud Pharma, the Czech subsidiary of Stada Arzneimittel, the German generic drugs manufacturer, generated sales of €5.5m in the Czech Republic, a decrease of 6% in comparison with the same period of 2009. After adjustments due to the changes in the group portfolio and exchange rate movements, the sales decreased by 9%.
The major activity was sales of generic drugs, which in H1 2010 accounted for €4.7m, down by 2% y-o-y. Sales of branded products decreased by 22% y-o-y to €0.9m.In 2009 the sales of Stada in the Czech Republic increased by 30% in local currency or by 23% in euro equivalent, reaching €12.2m. In 2008 the sales were €10m.